HUMOverviewFundamentalsDividendsTechnicalsRiskCatalystsNewsFinancial DataAIQ Pro
Current stock page

Catalysts

HUM Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Healthcare PlansScore data as of Sep 4, 2026

HUM

Catalysts
Humana Inc.
Healthcare· Medical - Healthcare Plans
AIQ Score
NeutralAIQ Edge 7/10
Low Priority
Above Peers
Score data as of Sep 4, 2026
Last price
$401.54
-$4.98 (-1.23%)
Latest market quote
Momentum80
Value55
Quality32
Risk Resilience60
Sentiment50
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 6, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 55/100

Momentum 80/100 and sentiment 50/100 before the next covered event.

Recent coverage
4 articles

Updated Sep 6, 2026 · Sentiment 31.37%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 80/100AIQ Edge 7/10 Above Peers
Beat rate
100%
8 of 8 reported periods
Average surprise
+7.9%
Across covered historical reports
Latest result
+4.7%
Jul 29, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Jul 29, 2026—$7.27$7.61+4.7%$40.58B$40.87B
Apr 29, 2026—$10.24$10.31+0.7%$39.37B$39.65B
Feb 11, 2026—-$4.00-$3.96+1.0%$32.04B$32.52B
Nov 5, 2025—$2.93$3.24+10.6%$32B$32.65B
Jul 30, 2025—$5.92$6.27+5.9%$31.87B$32.39B
Apr 30, 2025—$10.07$11.58+15.0%$32.2B$32.11B
Feb 11, 2025—-$2.23-$2.16+3.1%$28.81B$29.21B
Oct 30, 2024—$3.40$4.16+22.4%$28.68B$29.4B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
12
Buy
13
Hold
1
Sell
12-month analyst target
$345.17
-14.04% versus current price
Based on 19 analyst observations. Targets are estimates, not predictions.
Low target
$180.00
-55.17% vs latest price
Average target
$345.17
-14.04% vs latest price
High target
$513.00
+27.76% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 6, 2026

Next known earnings or reporting date.

EPS estimate-$1.00

Current analyst expectation for the upcoming report.

Revenue estimate$40.87B

Current analyst expectation for the upcoming report.

Sentiment score50

News pressure around the setup.

Momentum score80

Where event reaction would show up first.

AIQ score55/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
19
Average target
$345.17
Target upside
-14.04%
Target range
$180.00 - $513.00
90-day revisions
-7

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
0
finance.yahoo.com · Sep 3, 2026

Can Better Star Ratings and Margin Expansion Drive Humana (HUM) Higher?

Eagle Capital Management, an investment management company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. In the quarter, Eagle Capital Management discussed how enthusiasm around AI capital spending has driven strong S&P 500 earnings growth while also increasing risks from elevated valuations, concentrated demand, and aggressive investment assumptions. […]

gurufocus.com · Sep 2, 2026

HUM Looks 5.8% Overvalued on GF Value™ as Dividend Holds Steady

On September 02, 2026, Humana Inc (NYSE: HUM) announced a quarterly dividend of $0.885 per share, maintaining its previous payout level. The dividend carries a

gurufocus.com · Sep 1, 2026

Humana (HUM) Reaffirms FY 2026 EPS Guidance Ahead of Investor Meetings

Humana Inc. (HUM) announced on Tuesday that it will reaffirm its financial guidance for the fiscal year 2026 during a series of meetings with investors and ana

finance.yahoo.com · Aug 30, 2026

Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October.

A non-renewal notice from Humana can feel like bad news, but buried inside federal Medicare rules is a protection that most long-time Advantage members have no idea they still qualify for.

Open full news and sentiment

Related Links

HUM Catalysts FAQ

What are the next catalysts for HUM stock?

HUM's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move HUM stock?

Upcoming events that could move HUM include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could HUM's next earnings report affect the stock?

HUM's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive HUM stock higher?

HUM could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt HUM stock?

HUM could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.